Compare AAPG & PBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AAPG | PBH |
|---|---|---|
| Founded | 2009 | 1996 |
| Country | China | United States |
| Employees | 767 | 890 |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.3B |
| IPO Year | N/A | 2004 |
| Metric | AAPG | PBH |
|---|---|---|
| Price | $17.60 | $47.82 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 3 |
| Target Price | $48.40 | ★ $75.33 |
| AVG Volume (30 Days) | 8.8K | ★ 774.2K |
| Earning Date | 05-20-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 3.91 |
| Revenue | N/A | ★ $975,777,000.00 |
| Revenue This Year | $290.34 | N/A |
| Revenue Next Year | N/A | $4.31 |
| P/E Ratio | ★ N/A | $12.17 |
| Revenue Growth | N/A | ★ 36.77 |
| 52 Week Low | $16.92 | $42.62 |
| 52 Week High | $48.45 | $85.29 |
| Indicator | AAPG | PBH |
|---|---|---|
| Relative Strength Index (RSI) | 37.96 | 41.64 |
| Support Level | N/A | $44.51 |
| Resistance Level | $27.98 | $49.21 |
| Average True Range (ATR) | 0.74 | 1.55 |
| MACD | -0.06 | 0.49 |
| Stochastic Oscillator | 16.43 | 53.35 |
Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies and currently has seven drug candidates in pipeline under research. The company's geographical segments include the United States and Mainland China.
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.